ATE21625T1 - Ubidecarenone enthaltende, eingekapselte liposome. - Google Patents

Ubidecarenone enthaltende, eingekapselte liposome.

Info

Publication number
ATE21625T1
ATE21625T1 AT83104967T AT83104967T ATE21625T1 AT E21625 T1 ATE21625 T1 AT E21625T1 AT 83104967 T AT83104967 T AT 83104967T AT 83104967 T AT83104967 T AT 83104967T AT E21625 T1 ATE21625 T1 AT E21625T1
Authority
AT
Austria
Prior art keywords
ubidecarenone
containing encapsulated
encapsulated liposomes
liposome
liposomes
Prior art date
Application number
AT83104967T
Other languages
English (en)
Inventor
Masahiro Takada
Yatabe-Machi
Teruaki Yuzuriha
Kouichi Katayama
Junzo Sunamoto
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE21625T1 publication Critical patent/ATE21625T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT83104967T 1982-05-19 1983-05-19 Ubidecarenone enthaltende, eingekapselte liposome. ATE21625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57082993A JPS58201711A (ja) 1982-05-19 1982-05-19 ユビデカレノン含有リポソ−ム被覆体
EP83104967A EP0094692B1 (de) 1982-05-19 1983-05-19 Ubidecarenone enthaltende, eingekapselte Liposome

Publications (1)

Publication Number Publication Date
ATE21625T1 true ATE21625T1 (de) 1986-09-15

Family

ID=13789741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83104967T ATE21625T1 (de) 1982-05-19 1983-05-19 Ubidecarenone enthaltende, eingekapselte liposome.

Country Status (8)

Country Link
US (1) US4636381A (de)
EP (1) EP0094692B1 (de)
JP (1) JPS58201711A (de)
KR (1) KR840004512A (de)
AT (1) ATE21625T1 (de)
CA (1) CA1214392A (de)
DE (1) DE3365604D1 (de)
ES (1) ES522512A0 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH661438A5 (it) * 1984-04-09 1987-07-31 Seuref Ag Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
JPS61112021A (ja) * 1984-11-06 1986-05-30 Dai Ichi Seiyaku Co Ltd 脂質膜構造体
EP0287646B1 (de) * 1986-10-23 1992-05-20 Arval S.P.A. Ubidecarenon enthaltende kosmetische zusammensetzungen
US5320906A (en) * 1986-12-15 1994-06-14 Vestar, Inc. Delivery vehicles with amphiphile-associated active ingredient
JPS63313724A (ja) * 1987-06-16 1988-12-21 Eisai Co Ltd シアル酸修飾多糖被覆リポソ−ム
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
DE4433101A1 (de) * 1994-09-16 1996-03-21 Bauer Kurt Heinz Prof Dr Wasserlösliche Dextranfettsäureester und ihre Verwendung als Solubilisatoren
JP2000502087A (ja) * 1995-12-15 2000-02-22 ナショナル リサーチ カウンシル オブ カナダ アジュバンドおよび送達賦形剤としての、アーケオソーム類、補酵素q▲下10▼を含有するアーケオソーム類、および補酵素q▲下10▼を含有する他の種類のリポソーム類
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
EP1009383A1 (de) * 1997-09-04 2000-06-21 Biozone Laboratories, Inc. Orale liposomale verabreichungssysteme
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
ES2208268T3 (es) * 1999-01-15 2004-06-16 Cooperatieve Verkoop- En Productievereniging Van Aardappelmeel En Derivaten 'avebe' B.A. Derivados de almidon hidrofobos.
US6710038B1 (en) 1999-12-14 2004-03-23 Kibun Food Chemifa Co., Ltd. Emulsification method using propylene glycol hyaluronate
US8252322B2 (en) * 2003-06-03 2012-08-28 Corn Products Development, Inc. Delivery system with increased bioavailability
HRP20130459T1 (en) * 2004-01-22 2013-06-30 University Of Miami Topical co-enzyme q10 formulations and methods of use
JP2006137684A (ja) * 2004-11-10 2006-06-01 Nippon Fine Chem Co Ltd リポソーム前駆体の製造方法
JP5140913B2 (ja) * 2005-09-14 2013-02-13 日油株式会社 コエンザイムq10含有化粧料用リポソーム
JP2009536215A (ja) 2006-05-02 2009-10-08 ユニバーシティ オブ マイアミ 局所コエンザイムq10製剤、及び疼痛、疲労、並びに創傷の治療
US8454945B2 (en) 2007-03-22 2013-06-04 Berg Pharma Llc Topical formulations having enhanced bioavailability
EP2227085A4 (de) * 2007-12-06 2013-10-09 Berg Pharma Llc Inhalierbare zusammensetzungen mit gesteigerter biologischer verfügbarkeit
JP6058263B2 (ja) 2008-04-11 2017-01-11 バーグ リミテッド ライアビリティ カンパニー 癌細胞においてアポトーシスを誘導する方法および使用
US20110144376A1 (en) * 2008-08-20 2011-06-16 Showa Denko K.K. Dermatological agent
CN102481269B (zh) 2009-05-11 2015-10-07 博格有限责任公司 包含辅酶q10的药物组合物及其制备方法
BR112012022916B1 (pt) * 2010-03-12 2021-11-09 Berg Llc Formulações intravenosas de coenzima q10 (coq10), bem como método de preparação e uso da mesma
JP6092844B2 (ja) 2011-04-04 2017-03-08 バーグ エルエルシー 中枢神経系腫瘍の治療方法
US20140239525A1 (en) 2011-06-17 2014-08-28 Board Of Regents, University Of Texas System Inhalable pharmaceutical compositions
BR112015025424A2 (pt) 2013-04-08 2017-07-18 Berg Llc tratamento de câncer usando terapias de combinação de coenzima q10
CA2917921C (en) * 2013-07-17 2021-08-03 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
MX381399B (es) 2013-09-04 2025-03-12 Berg Llc Formulaciones de coenzima q10 y métodos de uso.
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CA3063916A1 (en) 2017-05-17 2018-11-22 Berg Llc Use of coenzyme q10 formulations in the treatment and prevention of epidermolysis bullosa
CN113262310A (zh) * 2021-03-02 2021-08-17 宿迁市第一人民医院 一种普鲁兰多糖修饰的人参皂苷Rg3纳米结构脂质载体及其制作方法
KR20250155058A (ko) * 2023-03-15 2025-10-29 유나이티드 이뮤니티 가부시키가이샤 지질 입자

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640707C3 (de) * 1976-09-10 1980-01-24 Karl Dr.Med. 7302 Ostfildern Theurer Verfahren zur Herstellung von Arzneipräparaten mit einem Gehalt an von im Darm resorbierbaren Protein und Peptidlösungen
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
FR2472384A1 (fr) * 1979-12-27 1981-07-03 Sederma Sa Utilisation en cosmetologie de complexes naturels constitues d'ubiquinones et de phospholipides
JPS5849311A (ja) * 1981-09-18 1983-03-23 Eisai Co Ltd 安全なるリポソ−ムの製造法

Also Published As

Publication number Publication date
ES8407095A1 (es) 1984-09-01
US4636381A (en) 1987-01-13
EP0094692A1 (de) 1983-11-23
JPS58201711A (ja) 1983-11-24
ES522512A0 (es) 1984-09-01
CA1214392A (en) 1986-11-25
EP0094692B1 (de) 1986-08-27
DE3365604D1 (en) 1986-10-02
KR840004512A (ko) 1984-10-22

Similar Documents

Publication Publication Date Title
ES8407095A1 (es) Un procedimiento de preparar un liposoma recubierto que contiene ubidecarenona.
AU542020B2 (en) Improvements in or relating to pumps
AU528436B2 (en) Diffusion and oxygenation
NO833992L (no) Minimalisering av virkningene av fiskehalesvingninger i vindturbiner
AU525310B2 (en) Improvements in and relating to the positioning of the end of an underwater flowline
EP0004182A3 (en) Improvements in or relating to audio teleconferencing
ES2032323T3 (es) Un procedimiento para la produccion de una preparacion antifungica formadora de pelicula.
IT8147509A0 (it) Perfezionamento nelle composizioni acquose contenenti enzimi stabilizzati
NO855084L (no) Konsentrert homogen vaskemiddelblanding i flytende form.
IT7949107A0 (it) Perfezionamento nelle paste dentifricie
GB8408883D0 (en) Antibody to candida fungi
IT8322824A0 (it) Metodo per ridurre il consumo energetico di cuscinetti.
JPS525568A (en) Driving method of indication
ZA787315B (en) Axial flow and partly axial flow pumps
JPS531980A (en) Pole assembling method
AU527511B2 (en) Improvements in or relating to anchors
SU682670A1 (ru) Погружной насос
AU4315679A (en) Axial-flow and partly axial-flow pumps
JPS51120275A (en) Humidity transducer and its production method
AU88051S (en) Winch
JPS54120196A (en) Impeller that simultaneously improve propulsion efficiency and stability of shipping
SE8505688D0 (sv) Rundjern att fora in i listen pa husvagnen
BG27986A1 (en) Method of determination the hydrolysis stability of lipids and the prohydrolysis effect of the lipase and nonlipase complex
JPS5297112A (en) Method of starting three-phase induction motor
CU21402A3 (en) Utilization of jasmonic and/or gibberellyc acid to increase the yields in the soja

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee